RxDoctor Payments Data

Renee Flower

Nurse Practitioner · Arlington, TXNPI 1457933715

Payments from drug & device makers

$5,150in general payments, 2019–2025

Across 206 payments — averaging $25.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$517
  • Lilly USA, LLC$309
  • Daiichi Sankyo Inc.$282
  • Bristol Myers Squibb$281
  • Merck$278
  • AbbVie$262
  • plus $3K from 45 others

What the payments were for

  • Food & beverage$4,56689%
  • Education$58411%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,150 in reported general payments places this provider in the 90th percentile of 5,422 nurse practitioner providers in Texas.

See all nurse practitioner providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin157$185,079
XareltoRivaroxaban13$21,870
Ranolazine ErRanolazine43$4,760
Metoprolol Succinate121$2,003
Nitroglycerin PatchNitroglycerin33$1,723
Midodrine Hcl12$744
Spironolactone65$419
ClopidogrelClopidogrel Bisulfate42$383
Atorvastatin Calcium36$240
Losartan Potassium17$203
Enalapril Maleate16$172
Carvedilol28$164
Amlodipine Besylate13$104
Furosemide16$101
Metoprolol Tartrate13$78

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$220$185,079157 claims
Johnson & JohnsonXarelto$213$21,87013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,422 nurse practitioner providers in Texas.

Other nurse practitioner in Arlington

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →